IRIS Accounts Production v24.2.0.383 13147614 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh131476142022-12-31131476142023-12-31131476142023-01-012023-12-31131476142021-12-31131476142022-01-012022-12-31131476142022-12-3113147614ns15:EnglandWales2023-01-012023-12-3113147614ns14:PoundSterling2023-01-012023-12-3113147614ns10:Director12023-01-012023-12-3113147614ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3113147614ns10:SmallEntities2023-01-012023-12-3113147614ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3113147614ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3113147614ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3113147614ns10:AbridgedAccounts2023-01-012023-12-3113147614ns10:Director22023-01-012023-12-3113147614ns10:RegisteredOffice2023-01-012023-12-3113147614ns5:CurrentFinancialInstruments2023-12-3113147614ns5:CurrentFinancialInstruments2022-12-3113147614ns5:ShareCapital2023-12-3113147614ns5:ShareCapital2022-12-3113147614ns5:RetainedEarningsAccumulatedLosses2023-12-3113147614ns5:RetainedEarningsAccumulatedLosses2022-12-31
REGISTERED NUMBER: 13147614 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

THE MAGIC MOLECULE COMPANY LTD

THE MAGIC MOLECULE COMPANY LTD (REGISTERED NUMBER: 13147614)

CONTENTS OF THE FINANCIAL STATEMENTS
For The Year Ended 31 December 2023










Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 3


THE MAGIC MOLECULE COMPANY LTD

COMPANY INFORMATION
For The Year Ended 31 December 2023







DIRECTORS: J R Salvage
D N Sharpe





REGISTERED OFFICE: Suite H1
Elm House
Tanshire Park
Elstead
Surrey
GU8 6LB





REGISTERED NUMBER: 13147614 (England and Wales)

THE MAGIC MOLECULE COMPANY LTD (REGISTERED NUMBER: 13147614)

ABRIDGED BALANCE SHEET
31 December 2023

2023 2022
£    £   
CURRENT ASSETS
Stocks 65 95
Debtors 655 440
Cash at bank 51 -
771 535
CREDITORS
Amounts falling due within one year 99,431 97,360
NET CURRENT LIABILITIES (98,660 ) (96,825 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(98,660

)

(96,825

)

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings (98,760 ) (96,925 )
(98,660 ) (96,825 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 December 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 7 August 2024 and were signed on its behalf by:





D N Sharpe - Director


THE MAGIC MOLECULE COMPANY LTD (REGISTERED NUMBER: 13147614)

NOTES TO THE FINANCIAL STATEMENTS
For The Year Ended 31 December 2023


1. STATUTORY INFORMATION

The Magic Molecule Company Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have been prepared on a going concern basis, which the directors consider to be appropriate, as they have agreed to provide the necessary finance to enable the company to meet its liabilities as they fall due.

Turnover
Turnover represents sales of biostimulants, excluding value added tax, sold during the year.

Turnover is recognised as the right to consideration arises and adjustments are made for accrued and deferred income.

Stocks
Stocks are stated at the lower of cost and estimated selling price, less costs to complete and sell. Cost includes all costs of purchase, including costs to bring stock to its present location and condition. Provision is made for damaged, obsolete and slow-moving stock where appropriate

Financial instruments
The company enters into basic financial instruments, which result in the recognition of financial assets and liabilities. Financial instruments are recognised at amortised cost. At the end of each reporting period financial instruments are assessed for evidence of impairment, and changes are recognised in profit or loss.

Taxation
Taxation for the year comprises current tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods.

Consideration is given to whether deferred tax should be provided in respect of material timing differences which have not reversed at the balance sheet date. Deferred tax assets are only recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or future taxable profits.

Current tax assets and liabilities are not discounted and are recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .